RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT)
CUSIP: 75382E208
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 27,748,559
- Total 13F shares
- 27,200,695
- Share change
- +13,577,455
- Total reported value
- $921,288,979
- Put/Call ratio
- 1.3%
- Price per share
- $33.87
- Number of holders
- 99
- Value change
- +$461,871,577
- Number of buys
- 82
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 75382E208?
CUSIP 75382E208 identifies RAPT - RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q3 2025
Recent filing periods for CUSIP 75382E208:
Institutional Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT) as of Q4 2025
As of 31 Dec 2025,
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,200,695 shares.
The largest 10 holders included
TCG Crossover Management, LLC, FCPM III SERVICES B.V., ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, Foresite Capital Management VI LLC, Siren, L.L.C., VANGUARD GROUP INC, Frazier Life Sciences Management, L.P., BRAIDWELL LP, and Redmile Group, LLC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
60
Q4 2025 holders
99
Holder diff
39
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.